Prothena Corporation PLC (NASDAQ:PRTA)

35.44
BATS BZX Real-Time Price
As of 10:56am ET
 +0.47 / +1.34%
Today’s Change
27.19
Today|||52-Week Range
70.00
-5.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.4B

Company Description

Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded on December 20, 2012 and is headquartered in Dun Laoghaire, Ireland.

Contact Information

Prothena Corp. Plc
Adelphi Plaza
Dun Laoghaire Dublin 927
P:(531) 236-2500
Investor Relations:
(650) 837-8535

Employees

Shareholders

Mutual fund holders85.52%
Individual stakeholders8.36%
Other institutional28.09%

Top Executives

Gene G. KinneyPresident, Chief Executive Officer & Director
Tran B. NguyenChief Financial Officer
Wagner ZagoChief Scientific Officer
Tara NickersonChief Business Officer
Karin L. WalkerChief Accounting Officer & Controller